Top Markets
Coin of the day
ACRO Biomedical Co., Ltd. ACRO Biomedical Co., Ltd.

ACRO Biomedical Co., Ltd.

6748
Rank in Stocks #15000
ACRO Biomedical Co., Ltd. is dedicated to the creation and manufacturing of... ACRO Biomedical Co., Ltd. is dedicated to the creation and manufacturing of biomaterial-based medical devices, specifically designed for applications in human tissue engineering and regenerative medicine. This company was established on June 26, 2014, and operates primarily from its headquarters in Kaohsiung, Taiwan.
Share Price
$5.33
Last synced: 2026-07-31
Market Cap
$379.33M
Change (1 day)
8.06%
Change (1 year)
119.29%
Country
TW
Trade ACRO Biomedical Co., Ltd. (6748)

Category

P/E ratio for ACRO Biomedical Co., Ltd. (6748)
P/E ratio as of 2026 TTM: 0
According to ACRO Biomedical Co., Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for ACRO Biomedical Co., Ltd. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.